PRISM MarketView

AI Drug Discovery Predicative Oncology (POAI) Rises 70% on Successful Ovarian Cancer Study, Enters Biomarker Discovery Market

New York, July 25, 2024 - PRISM MarketView - Today the PRISM NextGen Tech and AI Index leader Predicative Oncology (POAI) announced it will enter the $51.5M biomarker discovery market. This decision to expand their AI/ML driven drug discovery platform to pursue discovery...

25 July 2024

AI Datacenters and Infrastructure May Be the Next AI Related Play. Here’s Where to Look

New York, July 24, 2024 - PRISM MarketView - As artificial intelligence (AI) continues to grow in significance, the infrastructure supporting AI technologies has also evolved. This also opens a new door for opportunities related to AI as investors look to boost portfolio...

24 July 2024

Got Oats? Oatly (OTLY) Reports Q2 Earnings Beats Estimates, Raises Guidance

New York, July 24, 2024 - PRISM MarketView - The PRISM Consumer Products Index company Oatly Group AB (OTLY) reported its Q2 financials beating estimates on EPS ($0.05) vs FactSet (0.07), revenues $202.2M vs FactSet $201.3M and adjusted EBITDA ($11.0M) vs FactSet ($15.8M...

24 July 2024

Mammoth (TUSK) Moves Ahead in PRISM Oil and Gas Index on Settlement Agreement, up ~24%

New York, July 23, 2024 - PRISM MarketView - The PRISM Oil and Gas Index is currently led by Mammoth Energy Services (TUSK) on an announcement related to its wholly owned subsidiary, Cobra Acquisitions LLC regarding a settlement agreement it has entered into with the Pue...

23 July 2024

Emerging PRISM Index Cannabis Companies Slated to Report Earnings

New York, July 22, 2024 - PRISM MarketView - Today the PRISM Emerging Cannabis Index was a on a high as every name comprising the index ended the day green with the exception of Clever Leaves (CLVR) who remained flat. The largest leader of the group was Canopy Growth Cor...

22 July 2024

MIRA Pharmaceuticals (MIRA) Up Over 400% on Positive Preclinical Study Results Related to Ketamine in Treatment of Neurological Disorders

New York, July 22, 2024 - PRISM MarketView - Today the leading pre-clinical pharmaceutical company, MIRA Pharmaceuticals, Inc. (MIRA) announced new preclinical study results for its novel oral ketamine analog, Ketamir-2 which, is under investigation for its potential in ...

22 July 2024

Gute Nachrichten! Tilray (TLRY) Receives First New Cannabis Cultivation License in Germany

New York, July 22, 2024 - PRISM MarketView - PRISM Cannabis Index company Tilray Brands, Inc. (TLRY), a global leader in cannabis research, cultivation, production, and distribution, announced today that its German cannabis cultivation facility, Aphria RX GmbH, has recei...

22 July 2024

ChargePoint (CHPT) Powers Forward: Leading the NEVI Program with First Phase Completion in Rhode Island

New York, July 19, 2024 - PRISM MarketView - PRISM Emerging EV Index company, Chargepoint (CHPT) is a leading provider of networked charging solutions for electric vehicles (EVs). Today, the company announced its ongoing leadership in enabling DC fast charging at locatio...

19 July 2024

Making Money and Music: LiveOne (LVO) Reports Preliminary Record-Breaking Q1 Revenue and EBITDA

New York, July 19, 2024 - PRISM MarketView - AdTech and Media Index company and creator-first music tech platform LiveOne (LVO) announced preliminary and unaudited results for its first quarter. The company anticipates record revenue of $33.1M, an increase of 20% from th...

19 July 2024

Bionomics Kicks Off Phase 3 Trial for Promising Social Anxiety Disorder Treatment

New York, July 18, 2024 - PRISM MarketView - Bionomics Limited (Nasdaq: BNOX) has begun patient screening for its Phase 3 AFFIRM-1 clinical trial, evaluating the safety and efficacy of BNC210 for the acute, as-needed treatment of social anxiety disorder (SAD). BNC210 is ...

18 July 2024